Materias dentro de su búsqueda.
Mostrando 2,581 - 2,600 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.74s Limitar resultados
  1. 2581
    “…The aim of our study was to assess the risk of pancreatic cancer among long-term PPI users in Sweden. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
  2. 2582
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pegylated G-CSF Combined with mFOLFIRINOX for Advanced Pancreatic Cancer Patients
  3. 2583
    “…BACKGROUND: Pancreatic cancer (PAC) is a lethal cancer and it is essential to develop accurate diagnostic and prognostic biomarkers for PAC. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer
  4. 2584
    “…These findings could inform cancer immunotherapeutic strategies for targeting MAGEA antigens and provide mechanistic insight into the divergent roles of MAGEA6 during pancreatic cancer initiation and progression.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression
  5. 2585
    “…Traditional therapies have limited efficacy in hepatocellular carcinoma, pancreatic cancer, and biliary tract cancer, especially for advanced and refractory cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Oncolytic virotherapy in hepato‐bilio‐pancreatic cancer: The key to breaking the log jam?
  6. 2586
    “…Conclusion: COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer (COMMUNI. CARE) will be the first study specifically investigating whether there is a relation between PDAC patients' engagement, rate of understanding at the time of diagnosis, and compliance.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol
  7. 2587
    “…Pancreatic cancer (PC) is one of the most malignant tumors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer
  8. 2588
    “…Pancreatic cancer represents one of the most lethal disease worldwide but still orphan of a molecularly driven therapeutic approach, although many genomic and transcriptomic classifications have been proposed over the years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis
  9. 2589
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
  10. 2590
    “…Therefore, we used radiomic features of primary pancreatic tumors to develop outcome prediction models and compared them to traditional clinical models. (2) Methods: We extracted and analyzed radiomic data from pre-radiation contrast-enhanced CTs of 74 pancreatic cancer patients undergoing stereotactic body radiotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy
  11. 2591
    “…In this article, we propose a guidance to the management of pancreatic cancer during the pandemic, prioritised according to a three-tiered framework, and based on expert clinical judgement and magnitude of benefit expected from specific interventions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer
  12. 2592
    “…BACKGROUND: Several reports have shown the role of glycosylation in pancreatic cancer (PC), but a global systematic screening of specific glycosyltransferases (glycoTs) in its progression remains unknown. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis
  13. 2593
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients
  14. 2594
    “…Both KRAS and EGFR are essential mediators of pancreatic cancer development and interact with Argonaute 2 (AGO2) to perturb its function. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development
  15. 2595
    “…Pancreatic cancer is characterized by a 5-year survival rate of 3%, in part due to inadequate detection methods. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Phage Display Selection, Identification, and Characterization of Novel Pancreatic Cancer Targeting Peptides
  16. 2596
    “…EUS-guided thermal ablation is primarily used for pancreatic cancer. It is well suited to this disease because of its superior anatomical access compared with other imaging modalities and the dismal prognosis despite improvements in chemoradiotherapy and surgery in the management of pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Systematic review of endoscopy ultrasound-guided thermal ablation treatment for pancreatic cancer
  17. 2597
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines
  18. 2598
    “…BACKGROUND: Cancer subtype switching, which involves unclear cancer cell origin, cell fate decision, and transdifferentiation of cells within a confined tumor microenvironment, remains a major problem in pancreatic cancer (PDA). RESULTS: By analyzing PDA subtypes in The Cancer Genome Atlas, we identified that epigenetic silencing of apoptosis-associated tyrosine kinase (AATK) inversely was correlated with mRNA expression and was enriched in the quasi-mesenchymal cancer subtype. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer
  19. 2599
    por Zhang, Yifan, Lei, Qun-Ying
    Publicado 2020
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment
  20. 2600
    “…Pancreatic cancer is an aggressive, solid tumor, with a grave prognosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis
Herramientas de búsqueda: RSS